MetLife Investment Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1529735
Whippany, NJ
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,846,104
-$2,770,714 QoQ
Shares Held
58,072
-18.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#215
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. VRTX ranks #3 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,846,104 | 58,072 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,616,818 | 70,804 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $33,222,674 | 73,281 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $29,689,053 | 75,807 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $34,346,289 | 77,148 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $35,082,060 | 72,361 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $29,753,086 | 73,884 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $33,955,955 | 73,011 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $35,078,536 | 74,839 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $29,298,320 | 70,090 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $29,406,347 | 72,271 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $25,612,441 | 73,654 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $26,462,928 | 75,198 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $23,932,717 | 75,960 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $22,130,944 | 76,636 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $22,608,151 | 78,083 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $22,203,361 | 78,794 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $19,266,110 | 73,825 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $12,336,030 | 56,175 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $10,628,365 | 58,594 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $12,101,026 | 60,016 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $13,312,220 | 61,949 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $14,925,107 | 63,151 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $17,970,804 | 66,040 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $19,686,211 | 67,811 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $15,772,277 | 66,284 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||